NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1174547202 M.D.
Verify on CMS → Catherine Steffee, M.D.
Ophthalmology Physician in Greenville, North Carolina.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,388 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 414 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.9/100
▲ 15 pts above national avg 83.5 · Exceptional
Industry payments
$16.24
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Catherine Steffee, M.D. reported a CMS MIPS final score of 98.9/100 - above the 83.5 national average - and filed 1,684 Medicare Part D claims in 2024.
- 98.9/100
- MIPS score · +15 vs avg
- 2K
- Part D claims, 2024
- 59%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Catherine Steffee, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1174547202), first enumerated 07/26/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,684 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 98.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$16.24 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1174547202 · Ophthalmology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ELITE · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1174547202
- ENUM-LEGACY 2006
- TAX-MID 22K Ophthalmology Physician
- MIPS-ELITE 98.9/100
- RX-MID 1,684
- BOOK-LIGHT 622 in North Carolina
- PHOTO-FINISH Corey Miller, M.D. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Albert Lin, MD ·…
Albert Lin, MD
98.8 MIPS pts
- Steffee · this p…
Steffee · this provider
98.9 MIPS pts
- Corey Miller, MD…
Corey Miller, MD
98.9 MIPS pts
- Corey Miller, M.…
Corey Miller, M.D.
98.9 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Catherine Steffee, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
99 ≥ 89th percentile 89% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Catherine Steffee, M.D. sits
This provider among ophthalmology physician peers
Across the 8,767 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Catherine Steffee, M.D. writes more Part D claims than 65% of them and scores higher on MIPS quality than 81% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Catherine Steffee, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Catherine Steffee, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Catherine Steffee, M.D.?
High performer (top quartile)Primary specialty
Ophthalmology Physician
Medicare Part D claims
1,684 13% vs specialty avg
MIPS final score
98.9/100 15.4 pts vs avg
Specialty distribution in North Carolina
How Ophthalmology Physician compares to other specialties among North Carolina providers
Medicare quality performance, MIPS
Catherine Steffee, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 98.9/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1174547202 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 07/26/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
98.852
Final Score
Measured-score avg: 83.5
97.7039
Quality
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Catherine Steffee, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$16
Largest payer
Oyster Point Pharma, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Catherine Steffee, M.D. - brand share 41.0%
Ophthalmology Physician average
41% brand-name claims vs 59% generic, on 1,684 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,684
Total Claims
$338K
Total Drug Cost
414
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,005.833
- Total Day Supply
- 86,338
- Brand vs Generic
- 41% brand / 59% generic
- Brand Drug Cost
- $304K
- Generic Drug Cost
- $34K
- Antibiotic Claims
- 12
Patient Demographics
- Average Patient Age
- 79.2 years
- Avg HCC Risk Score
- 1.18
- Gender Split
- 70% female / 30% male
- Age Distribution
- <65: 11, 65-74: 109, 75-84: 187, 85+: 107
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Catherine Steffee, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Latanoprost
Latanoprost
469 claims
- Timolol Maleate 169
Timolol Maleate
169 claims
- Restasis 154
Restasis
154 claims
- Brimonidine Tartrate 103
Brimonidine Tartrate
103 claims
- Lumigan 84
Lumigan
84 claims
- Combigan 75
Combigan
75 claims
- Dorzolamide-Timolol 66
Dorzolamide-Timolol
66 claims
- Ketorolac Trometha… 57
Ketorolac Tromethamine
57 claims
| Drug | Claims |
|---|---|
| Latanoprost | 469 |
| Timolol Maleate | 169 |
| Restasis Cyclosporine | 154 |
| Brimonidine Tartrate | 103 |
| Lumigan Bimatoprost | 84 |
| Combigan Brimonidine Tartrate/Timolol | 75 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 66 |
| Ketorolac Tromethamine | 57 |
| Xiidra Lifitegrast | 56 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 51 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Catherine Steffee, M.D. fits within the Ophthalmology Physician landscape nationally.
22,388
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,490
Avg Claims per Provider
Catherine Steffee, M.D.'s 1,684 claims are above the specialty average of 1,490.
Nationwide Ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Steffee, both outside North Carolina so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (98.9 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmology Physician Providers in North Carolina
Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as Steffee.
One of 622 Ophthalmology Physician providers enrolled in North Carolina, 5 are shown here.
Dr. Brian Adair
M.D.
Hickory, NC
Dr. Lindsay Adam
M.D.
Raleigh, NC
Modupe Adetunji
Durham, NC
Dr. Richard Akers
M.D.
Gastonia, NC
Dr. Richard Akers
M.D.
Morganton, NC
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Catherine Steffee, M.D.'s specialty? ▼
Catherine Steffee, M.D. specializes in Ophthalmology Physician and practices in Greenville, North Carolina. Credentials: M.D..
How much does Catherine Steffee, M.D. prescribe under Medicare Part D? ▼
In 2024, Catherine Steffee, M.D. wrote 1,684 Medicare Part D claims totaling $338K in drug costs for 414 beneficiaries.
What is Catherine Steffee, M.D.'s Medicare quality score? ▼
Catherine Steffee, M.D. has a CMS MIPS Final Score of 98.9/100 (Quality: 97.7). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Catherine Steffee, M.D. located? ▼
Catherine Steffee, M.D. is located at 2425 HEMBY LN, Greenville, NC, 27834. Phone: (252) 758-4166.
What is Catherine Steffee, M.D.'s NPI number? ▼
Catherine Steffee, M.D.'s National Provider Identifier (NPI) is 1174547202, issued on 07/26/2006.
Does Catherine Steffee, M.D. prescribe more brand-name or generic drugs? ▼
Catherine Steffee, M.D.'s prescribing is 41% brand-name and 59% generic drugs by claim count, with $304K in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,388 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,490 Medicare Part D claims per year.
What drugs does Catherine Steffee, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Catherine Steffee, M.D.'s most frequently prescribed drugs include Latanoprost, Timolol Maleate, Restasis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Catherine Steffee, M.D. accept Medicare? ▼
Catherine Steffee, M.D. appears in CMS Medicare data with 1,684 Part D claims and 414 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Catherine Steffee, M.D.'s credentials? ▼
Catherine Steffee, M.D.'s NPI is 1174547202 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.